After Cassava Fraud Indictment, Questioning the Ethics of Simufilam Trial
On September 26th, Cassava Sciences’ founder and former CEO Remi Barbier, as well as former vice president Lindsay Burns agreed to pay the Securities…
On September 26th, Cassava Sciences’ founder and former CEO Remi Barbier, as well as former vice president Lindsay Burns agreed to pay the Securities…
While the world tracks the progress of disease-modifying Alzheimer’s anti-amyloids through the drug development and FDA approval pipeline, there are symptomatic treatments making their…
No one can tell for certain if you’ll develop Alzheimer’s disease 10, 20 or 30 years from now — but you can certainly lower…
Getting an accurate Alzheimer’s diagnosis can take years — and several visits to the doctor. After taking a medical history, neurological exam, and blood tests…
According to legend, Kaldi, an Ethiopian goat herder who lived more than 1000 years ago, noticed something curious about his goats: If they ate…
Have you made that free flu shot appointment at your local pharmacy yet? The data shows that people who skip their flu shot had…
More than one billion adults worldwide have high blood pressure, but since it doesn’t often cause symptoms, half of them don’t even know they…
Treatment with a powerful magnet is one of the newest experimental therapies being used to try to turn back the clock on Alzheimer’s disease….
Maybe you’ve heard of amyloid plaques, which build up in the brains of people with Alzheimer’s. But there’s another protein biomarker in the mix:…
Athira Pharma’s experimental Alzheimer’s drug fosgonimeton hit a speedbump on its way toward FDA approval: The treatment failed to show a clinical benefit in…
In February, Biogen announced it was pulling Aduhelm off the market. The company will continue supplying the drug until November but stopped providing it…
More than one in ten people who catch COVID don’t fully recover — developing a chronic condition called long COVID which causes a variety…
A new definition of Alzheimer’s has been published — and it’s drawing a lot of criticism. According to this set of new diagnostic criteria…
On August 22nd, the UK’s drug regulation agency — UK Medicines and Healthcare products Regulatory Agency — approved Eisai and Biogen’s anti-amyloid drug Leqembi…
Some early studies suggested a class of diabetes drugs called GLP-1 agonists, which have been proven to also help people lose weight and reduce…